COVID-19: Vaccines and Therapeutics

Feb 18, 2022
The Centers for Medicare & Medicaid Services has released Medicare payment codes effective Feb. 11 for administering the monoclonal antibody bebtelovimab, effective against the omicron COVID-19 variant.
Feb 16, 2022
COVID-19 has demonstrated that in health care, change is not only necessary, it’s happening every day — leading to better access, better outcomes and a more pleasing patient experience.
Feb 15, 2022
Receiving two doses of the Pfizer or Moderna COVID-19 vaccine during pregnancy might help prevent your infant from being hospitalized for COVID-19 in the first six months after birth, according a study released today by the Centers for Disease Control and Prevention.
Feb 14, 2022
During the omicron wave, the Pfizer or Moderna COVID-19 vaccine was 87% effective at preventing emergency and urgent care visits and 95% effective at preventing hospitalizations in adults who received a third dose in the prior two months, according to a study released by the Centers for Disease…
Feb 11, 2022
Pfizer will delay asking the Food and Drug Administration to authorize its COVID-19 vaccine for children under age 5 until it has clinical trial data on a third dose in this age group, which it expects in early April.
Feb 11, 2022
As the state with the highest percentage of its population vaccinated, Vermont continues to urge that children become vaccinated and everyone receive a booster.
Feb 9, 2022
As rural health care leaders from the AHA and other health care organizations convened at AHA’s Rural Health Care Leadership Conference this week, a robust discussion took place over the role hospital and health system trustees can play in building confidence in the COVID-19 vaccines in their rural…
Feb 7, 2022
On a recent AHA webinar with the Centers for Disease Control and Prevention, health care leaders discussed key strategies for building among pregnant people trust in the safety and efficacy of COVID-19 vaccines.
Feb 7, 2022
The Centers for Disease Control and Prevention Friday endorsed the Food and Drug Ad
Feb 7, 2022
On a recent AHA webinar, health care leaders discussed key strategies for building trust in the safety and efficacy of the COVID1-9 vaccines among pregnant people.